Momenta Pharmaceuticals to Webcast Presentation at Two Upcoming Investor Conferences
May 10, 2017 12:03 pm UTC| Business
CAMBRIDGE, Mass., May 10, 2017 -- Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that it will webcast its...
Argos Provides Update on its ADAPT Trial Following Meeting with FDA
May 10, 2017 12:03 pm UTC| Business
DURHAM, N.C., May 10, 2017 -- Argos Therapeutics Inc. (NASDAQ:ARGS), an immuno-oncology company focused on the development and commercialization of individualized immunotherapies based on the Arcelis® precision...
Momenta Pharmaceuticals to Webcast Presentation at Two Upcoming Investor Conferences
May 10, 2017 12:03 pm UTC| Business
CAMBRIDGE, Mass., May 10, 2017 -- Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that it will webcast its...
UroGen Pharma Announces Closing of Initial Public Offering and Exercise of Underwriters’ Option
May 10, 2017 12:03 pm UTC| Business
RA’ANANA, Israel and NEW YORK, May 10, 2017 -- UroGen Pharma Ltd. (NASDAQ:URGN), a clinical stage biopharmaceutical company developing advanced non-surgical treatments to address unmet needs in the field of urology with...
UroGen Pharma Announces Closing of Initial Public Offering and Exercise of Underwriters’ Option
May 10, 2017 12:03 pm UTC| Business
RA’ANANA, Israel and NEW YORK, May 10, 2017 -- UroGen Pharma Ltd. (NASDAQ:URGN), a clinical stage biopharmaceutical company developing advanced non-surgical treatments to address unmet needs in the field of urology with...
UroGen Pharma Announces Closing of Initial Public Offering and Exercise of Underwriters’ Option
May 10, 2017 12:03 pm UTC| Business
RA’ANANA, Israel and NEW YORK, May 10, 2017 -- UroGen Pharma Ltd. (NASDAQ:URGN), a clinical stage biopharmaceutical company developing advanced non-surgical treatments to address unmet needs in the field of urology with...
May 10, 2017 12:03 pm UTC| Business
PLYMOUTH MEETING, Pa., May 10, 2017 -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) today announced MedImmune, AstraZeneca’s global biologics research and development arm, will start a new clinical trial investigating the...